appConfigEntityId

bodyType

customContents

entityId

entityUuid

isVideo

articlePageQuery

article

articleSchemaContent

content

hooksArticlePageAdvertisementConfigArticle

appConfig

filter

json

liveArticle

Reuters

Soon-to-be brides and grooms seeking ⁠short cuts to shed pounds before the big day have become the latest consumer target ⁠for weight-loss drugs in India.
New Delhi wellness clinic Klarity Skin Clinic touts a “Mounjaro bride” package, while other clinics have woven weight-loss injections into “pre-wedding” transformation packages typically focused on skin treatments and hairstyle makeovers.
In a social media video, Klarity offers “guided nutrition, Mounjaro and smart workouts” to prepare brides to walk down the aisle. The clinic did not respond to a request for comment.
Eight doctors said they had been fielding inquiries from brides, and some grooms, about taking weight-loss drugs before taking their vows.

Many asked for Eli Lilly’s Mounjaro, the first GLP-1 medication ‌to enter India’s market for both diabetes and weight loss. It was more sought after than Novo Nordisk’s rival Wegovy, the doctors said.
“Over the last few months, over 20 per cent of the queries we’ve received for obesity injections are from to-be brides, who also openly give us a timeline on how soon they are getting married,” said Rajat Goel, a bariatric surgeon at Hindivine Healthcare in New Delhi.
He said he prescribed the drugs only if patients were medically eligible, not for cosmetic use.
Weddings in India are grand affairs for families that can afford them, with culture and tradition exerting a strong influence. Many marriages continue to be arranged by families, often bringing expectations around physical appearance and financial status.
Happy with results
Aditi, a 26-year-old finance worker from Mumbai, consulted a doctor in November for a weight-loss prescription after exercise and diet failed to get the desired results.
“When I see the result, I feel happy,” Aditi said about losing 10kg (22lbs) on Mounjaro before her February wedding. “If I am not happy, I don’t feel confident. I did not want to feel ‌that way at the time of the wedding.”
She is one of the half a dozen brides, and one groom, who spoke about pre-wedding use of weight-loss drugs, but asked not to use their family names due to social stigmas.
They cited societal pressure to look a “certain way” at their wedding and most had discontinued the injections soon after.
Novo and Lilly launched their obesity drugs in India last year. The market is forecast to reach 80 billion rupees (US$86 million) by 2030. Mounjaro sales doubled in the months after launch, ⁠making it the highest-selling drug in the world’s ⁠most populous nation.

Indian drug makers began selling cheaper versions of Novo’s medicine last month after the patent on semaglutide, its active ingredient, expired, widening access.
The drugs are intended for adults classified as obese, or for those considered overweight with a weight-related medical condition such as diabetes, hypertension or sleep ‌apnoea.
“Mounjaro has been approved by regulators for specific medical indications and is intended to be used only under the supervision of a qualified healthcare professional,” Lilly said in a statement.
The lowest Mounjaro injection pen dose sells for 13,125 rupees per month in India, while the highest dose costs 25,781 rupees.
Novo, which ‌this week ‌cut prices of Ozempic and Wegovy for the second time, is selling the lowest Wegovy dose for 5,660 rupees and the highest for 16,400 rupees a month.
Novo said it discouraged any form of self-medication of semaglutide or ‌deviation from the indicated use on label.
Weighty woes
India could have more than 440 million overweight or obese people by 2050, one of the world’s highest totals, according to The Lancet.
Akshitha, who got married in Hyderabad last year, said the drugs helped her shed 15kg, taking her weight to 76kg before the wedding. A family doctor had suggested she try the injections when she worried about her weight, she said.
“There’s ⁠so much chaos before the wedding, with all the planning and preparation. I knew I would not get time to go to the gym and be on a diet. That’s when these drugs looked like a better option,” she said, adding she might consider using them again after a future pregnancy.

With local drug makers flooding the market with cheaper weight-loss medicines, India’s drugs regulator has raised concerns about misuse ‌and intensified scrutiny of unauthorised sales and promotion.
“We understand the ‌curiosity, but this cannot be a quick fix,” said Swati Pradhan, founder of obesity and metabolic wellness clinic Live Light.
The doctor said she prescribed the injections to only a few soon-to-be brides if they were medically eligible and showed signs of other medical issues, while insisting on lifestyle changes for sustainable results.
I’ve had men and their families reject my proposal because of my weight
Priya, a prospective bride
For 27-year-old Priya, a tech worker from Bengaluru, weight-loss drugs became a way to counter body-shaming from prospective grooms’ families.
“I’ve had men and their families reject my proposal because of my weight. I was told I was fat,” she said.
She initially used Novo’s oral semaglutide, approved in India for diabetes, as an off-label treatment and lost more than 12kg before switching to injectable Mounjaro.
Her search for a groom continues.


Asian airfares look set to fall as jet fuel prices ease on US-Iran deal

Indian tech hub names road for Trump, draws flak from PM Modi’s party

How Indonesia’s coal policies left its own citizens in the dark

Skip Rajasthan for Punjab: a luxurious stay at Ran Baas, The Palace in the former royal city of Patiala

India

Here comes the ‘Mounjaro bride’: Indian women turn to weight-loss drug before wedding

Brides sit during a mass marriage ceremony in Mumbai. Photo: AFP

A bridal couple perform rites at the groom’s house in Jaipur. Traditional Indian weddings are typically grand affairs. Photo: Shutterstock

Semaglutide drugs are intended for adults classified as obese, or for those with weight-related medical conditions such as diabetes, hypertension or sleep ‌apnoea. Photo: Instagram.com/glp1training

People shop at a market in Chennai. India could have more than 440 million overweight or obese people by 2050, one of the world’s highest totals, according to The Lancet. Photo: AFP

India’s weight-loss price war begins as semaglutide patent expires

A group of women walk on a street in Madurai, Tamil Nadu. About a quarter of India’s adult population is either overweight or obese. Photo: LightRocket via Getty Images

A man eating jalebi, an Indian sweet, at a market in Allahabad. Obesity is a rising problem in India due to an abundance of fatty and sugary foods. Photo: AP

Ozempic, wegovy and Rybelsus semaglutide medications are used by consumers to lose weight by suppressing their appetite. Photo: Shutterstock

As India and US seek to reset defence ties, Iran war threatens to be the wild card

Plumes of smoke rise following reported explosions close to Sepah Square in Tehran on March 1 amid the ongoing US-Israeli attacks on Iran. Photo: TNS 

US Under Secretary of Defence for Policy Elbridge Colby testifies before a Senate hearing on March 3 in Washington. Photo: Getty Images via AFP

A dockyard off the coastal city of Fujairah in the Strait of Hormuz in the northern Emirate. Iran has said it would let “non-hostile” oil vessels go through the crucial strait amid the ongoing Middle East war. Photo: AFP

Why India is quietly deepening its engagement with the Taliban

Afghan refugees recently returned from Pakistan and Iran receive rations donated by the Indian government, in Kabul, Afghanistan, on May 18, 2025. Photo: EPA-EFE

Afghanistan’s Trade Minister Nooruddin Azizi speaks at a meeting in New Delhi, India, on November 21. Photo: Reuters

‘China’s Ozempic’ may vie with Eli Lilly, Novo Nordisk for global weight-loss drug market

The market for weight-loss drugs could see new entrants among existing biotech firms. Photo: Shutterstock

Mounjaro, a drug used for treating type 2 diabetes, is manufactured by Eli Lilly. Photo Reuters

Ozempic, Wegovy and Rybelsus are semaglutide-based medications. Photo: Shutterstock

Diet drug used by Elon Musk helped these women lose weight – but experts warn there are drawbacks to taking it

Elon Musk smiles as he addresses guests at an event in Norway. Musk has said he lost weight using an injectable weight loss drug, semaglutide. Photo: Carina Johansen/NTB/AFP/Getty Images/TNS

A diabetic patient prepares to inject Ozempic, a brand name for semaglutide, to help control his blood sugar level. The injections are now being used by people to aid weight loss. Photo: Shutterstock

Ozempic is a brand name for a drug called semaglutide. 

Diane Tran is a nutritionist from Hong Kong’s Central Health clinic. Photo: Diane Tran

For those on semaglutide who continue to overeat or make unhealthy food choices, the impact on weight loss may be minimal. Photo: Shutterstock

Susan Jamieson is a doctor in Hong Kong. Photo: Susan Jamieson

Semaglutide is not a wonder drug where the weight automatically falls off you. You still have to watch what you eat and exercise regularly. Photo: Shutterstock

In Hong Kong, semaglutide can only be prescribed by a medical doctor – as there are many reasons a person may battle with weight, including undiagnosed health conditions. Photo: Shutterstock 

News

Asia

South Asia

Many Indian marriages are arranged by families, often bringing expectations around physical appearance and financial status


Many Indian marriages are arranged by families, often bringing expectations around physical appearance and financial status.


Medicine

Eli Lilly

Drugs

Here comes the ‘Mounjaro bride’: Indian women turn to weight-loss drug before wedding

.css-1c6uqr6{color:inherit;font-weight:inherit;font-size:inherit;font-family:inherit;line-height:inherit;overflow-wrap:break-word;}Many Indian marriages are arranged by families, often bringing expectations around physical appearance and financial status

Many Indian marriages are arranged by families, often bringing expectations around physical appearance and financial status